# Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III

> **NCT04308070** · NA · COMPLETED · sponsor: **PROCEPT BioRobotics** · enrollment: 26 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DEVICE:** AQUABEAM System followed by catheter without hemostatic agent
- **DEVICE:** AQUABEAM System followed by catheter with hemostatic agent

## Key facts

- **NCT ID:** NCT04308070
- **Lead sponsor:** PROCEPT BioRobotics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-18
- **Primary completion:** 2018-03-22
- **Final completion:** 2018-06-30
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2020-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04308070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04308070, "Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04308070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*